Purchase Order 36C24624P0927
Award Date 3/28/24
Potential Completion Date 9/30/24
Potential Value $84K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Earth City, MO 63045, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Foundation Care LLC, a specialty pharmacy, to provide the drug Iclusig (ponatinib). The contract has a potential value of $110,424.15 and a completion date of September 30, 2022. Foundation Care LLC is a subsidiary of Centene Corporation, a for-profit organization. The contract does not have a set-aside designation. Through this and other federal contract awards,...
- Foundation Care LLC, a for-profit specialty pharmacy and subsidiary of Centene Corporation, has been awarded a $13,956.72 firm-fixed-price purchase order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6. The contract is for the provision of Iclusig 15 mg tablets to the Earth City, Missouri VA medical center, with a period of performance through February 29, 2024. Iclusig is used to treat chronic myeloid leukemia and...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of ICLUSIG 15 mg tablets. The $14,197.39 contract supports the VA's mission of providing healthcare services to veterans by ensuring access to this critical oncology medication. The award is associated with Takeda Pharmaceuticals America, Inc.'s $123.5 million Blanket Purchase Agreement...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of ICLUSIG 15 MG, a specialty oncology medication, to VA medical facilities. The contract has a ceiling value of $14,197.39 and a completion date of October 8, 2025. Takeda Pharmaceuticals America, Inc. holds a $123.5 million Blanket Purchase Agreement (BPA) with the VA...
- This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $14,197.39, is for the delivery of ICLUSIG 15 MG, a specialty oncology medication, to VA medical facilities and Veterans Integrated Service Networks (VISNs) across multiple regions. The contract was awarded under the VA's General Services Administration (GSA) Schedule 61-IB...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $14,197.39 contract is for the supply of ICLUSIG 15 MG, a specialty oncology medication, to VA medical facilities. This delivery order is part of a larger $123.5 million Blanket Purchase Agreement (BPA) held by Takeda Pharmaceuticals America, Inc. under the General Services Administration (GSA)...
- This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract, valued at $13,956.72, is for the delivery of ICLUSIG 10 & 15 MG, a specialty oncology medication, to various VA medical facilities across the country. The contract was awarded against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals...
- This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $69,783.60 and supports the delivery of the oncology medication ICLUSIG (ponatinib) to VA medical facilities nationwide through September 2024. The contract is issued under Takeda's existing General Services Administration (GSA) Schedule 61-IB for...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the supply of the oncology medication ICLUSIG 15 MG, and is issued under Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The contract has a ceiling value of $14,197.39 and a completion date of February 25, 2025. This delivery order is part...
- This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract is for the supply of ICLUSIG 15 MG, an oncology medication, to the VA's Veterans Integrated Service Network 5 (VISN 5). The contract was awarded against Takeda's existing General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs, with a ceiling value of...